Pfizer
Sentiment Over Time
Analysis Timeline
"Cited as one of the most frequently shorted stocks, implying negative sentiment from some investors."
"Stock fell 3% after reporting a multi-billion dollar loss in the fourth quarter."
"Revenue decline due to reduced Covid-19 product demand and a cautious confirmed 2026 outlook resulted in a 5% stock drop."
"Acquired Zera/Metzera, signaling intent to compete in the GLP-1 market, though the acquisition was expensive and faced competitive concerns."
"Negativ betroffen von Trumps Ankündigung, dass Amerikaner nicht mehr für Medikamente zahlen sollen als Europäer."
"Lizenzdeal mit Novavax wurde angekündigt, was sich positiv auf den Partner auswirkte."